Multicentre, randomised, double-blind, parallel controlled trial to investigate timing of platelet inhibition after coronary artery bypass grafting: TOP-CABG trial study

Multicentre, randomised, double-blind, parallel controlled trial to investigate timing of platelet inhibition after coronary artery bypass grafting: TOP-CABG trial study

Introduction Dual antiplatelet therapy (DAPT), referred to as the combination of aspirin and P2Y12 receptor antagonist (clopidogrel or ticagrelor), potentially improves patency of saphenous vein grafts (SVG) after coronary artery bypass grafting (CABG), while it is further proposed that DAPT potenti...

Full description

Saved in:
Bibliographic Details
Main Authors: Yang Wang, Lihua Zhang, Shengshou Hu, Kai Chen, Xin Yuan, Qing Chu, Yingli Zheng
Format: Article
Language:English
Published: BMJ Publishing Group 2023-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/6/e070823.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items